The surgical treatments for benign prostate hyperplasia (BPH) has been changed and holmium laser enucleation of the prostate (HoLEP) has become to play larger role on it than before. HoLEP research tends to focus on the surgical outcomes but that of surgery education is not fully investigated. In this study, for the purpose of establishing the surgeon educational system of HoLEP, the data from 5 hospitals were investigated in order to find the answer for 1) how many cases do they need for reaching plateau of surgical time? 2) what should we do for prevention of adverse events?
INTRODUCTION AND OBJECTIVES:
The surgical treatments for benign prostate hyperplasia (BPH) has been changed and holmium laser enucleation of the prostate (HoLEP) has become to play larger role on it than before. HoLEP research tends to focus on the surgical outcomes but that of surgery education is not fully investigated. In this study, for the purpose of establishing the surgeon educational system of HoLEP, the data from 5 hospitals were investigated in order to find the answer for 1) how many cases do they need for reaching plateau of surgical time? 2) what should we do for prevention of adverse events?
METHODS: This is a multi-center retrospective study from a total of 1113 cases of HoLEP with full data for analysis as to surgery, preoperative prostate volume, postoperative urination-related factors such as maximal flow rate and residual urine volume and surgery related complication. Surgical procedure and the instrumentation of HoLEP are the same. Complications were categorized as intraoperative, postoperative short-term and long-term ones. The surgeons with less than 20 cases were supervised during HoLEP.
RESULTS: Total 1113 cases were done by 39 surgeons in 5 hospitals in these 10 years with median 24 cases experience. The statistical results showed HoLEP experience positively contributed only to surgical time, enucleation time and reducing postoperative urinary incontinence (p[0.0146, 0.0216 and 0.0405, respectively) even though patients 0 backgrounds are similar. These results are emphasized in 20 cases or more of experiences. However, more number of HoLEP experience did not contribute to morcellation time, resected prostate volume, infectious or noninfectious surgery related complications, or urination related outcomes (p>0.05). Moreover, moderately experienced surgeons (31-50 cases) had higher postHoLEP complications in larger prostate cases, suggesting the possibility that experience may make the surgeons lose caution in a way. CONCLUSIONS: Our data showed 20 cases experience positively contributed to shortened operative time and enucleation time and reducing postoperative urinary incontinence but not to surgery related complications or urination related outcomes as shown by maximum flow rate and post-void residual urine volume. We also found that moderately experienced surgeons had more complications in larger prostate cases. Based on them, we suggest as follows: 1) 20 cases are necessary for learning curve. 2) Reducing complications are always necessary to be paid attention. 3) Moderate experience might lose attention so we should not forget what we think in the initial case.
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MP01-18 ECONOMIC IMPACT OF THE INTRODUCTION OF LASER SURGERY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Serena Maruccia*, Ella Kinzikeeva, Paolo Spiga, Gianluca Cacace, Stefano Casellato, Monza, Italy INTRODUCTION AND OBJECTIVES: Since January 2017, with the reappointment of its urology staff, a new thulium laser has been introduced in the treatment of benign prostatic hyperplasia at the Zucchi Clinical Institutes of Monza.
Before the introduction of the thulium, surgery involved bTURP and prostatectomy carried out by two expert surgeons, each having performed more than 500 procedures. The new staff had equal expertise in the laser technique.
Hence, the economic and managerial impact of the introduction of the thulium laser surgery was examined in the treatment of benign prostatic hyperplasia.
METHODS: Together with our Health Directorate, we analysed all the bTURP and prostatectomy carried out in 2016, and we matched them with the ThuVEP carried out in 2017. We examined such factors as time spent in the operating room, length of hospital stay and cost of the procedure. We then examined the total number of procedures carried out from 2016 to the first three months of 2018.
RESULTS: The evidence shows that the number of procedures for prostatic hyperplasia has increased considerably (þ20%). The average duration of hospital stay has gone up from 7.2 (prostatectomy) and from 4.22 (bTURP) to 2 days with an average economy of 53% with TURP and of 72% with prostatectomy. The average cost of hospital stay is €674 per day (a). Surgical times decreased by 52% with prostatectomy and by 35% with TURP.
A ThuVEP cost/procedure is 25% higher than prostatectomy and 22% higher than bTURP. The elimination of transfusions alone has resulted in an economy of €2,353.80. The number of Thulep has increased by 79% from first three months of 2017 to the first three months of 2018.
CONCLUSIONS: Against a minimal increase in the cost/procedure, the introduction of laser surgery has considerably reduced costs in terms of occupation of the surgical room, hospital beds and elimination of requests of transfusions. The introduction of laser technology also entails an increase in the number of patients per specific pathology. The reduction of hospital stay and the increase in case studies suggest an overall optimization as well as rationalisation of human and structural resources.
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